FAIRFAX, Va., Dec. 11 /PRNewswire-USNewswire/ -- Nancy Sander, president and founder of Allergy & Asthma Network Mothers of Asthmatics (AANMA) today urged committee members to preserve patient access to all forms of 12-hour bronchodilators at a joint meeting of the Pulmonary-Allergy Drugs Advisory Committee, Drug Safety and Risk Management Advisory Committee and Pediatric Advisory Committee of the Food and Drug Administration held in Rockville, MD.
Sander also requested the committee use caution in their statements about this issue by avoiding confusing terms such as "rescue" and "controller" to describe affected asthma medications. Patients and prescribers should know these facts:
"When prescribed and used as part of a comprehensive treatment plan, 12-hour bronchodilators have given back to patients the ability to work, climb stairs, attend school, sleep through the night, and compete in sports - without symptoms - things most others take for granted," said Sander. "Until policies are in place to ensure that all patients diagnosed with asthma receive care according to the National Asthma Education Prevention Program (NAEPP) guidelines we will continue to see avoidable distress and deaths due to asthma. Patients need asthma care consistent with NAEPP guidelines and patient-centered care free of confusing jargon."
For more information please visit AANMA's Web site at www.breatherville.org. Patients seeking information can also call AANMA's Patient Support Center at 800.315.8056.
Founded in 1985, Allergy & Asthma Network Mothers of Asthmatics is the leading national nonprofit family organization dedicated to eliminating suffering and death due to asthma, allergies and related conditions. AANMA's core areas of expertise are education, advocacy and outreach. Call 800.878.4403 or visit www.breatherville.org.
|SOURCE Allergy & Asthma Network Mothers of Asthmatics|
Copyright©2008 PR Newswire.
All rights reserved